Variability of bone cell gene expression as a criterion to determine osteogenic capability of human mesenchymal stem cells
Osteoporosis is a skeletal disorder characterized by decreased BMD and the increased prospect of fracture. These fractures can have a detrimental impact on an individual’s standard of living and are sometimes fatal. Increased bone resorption by osteoclasts relative to the bone formation by osteoblas...
Main Author: | Lowry, Gabriela Juliet |
---|---|
Other Authors: | Gerstenfeld, Louis |
Language: | en_US |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/43451 |
Similar Items
-
Biomineral/Agarose Composite Gels Enhance Proliferation of Mesenchymal Stem Cells with Osteogenic Capability
by: Yoshika Suzawa, et al.
Published: (2015-06-01) -
Roles for miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells
by: Jicheng Wang, et al.
Published: (2019-06-01) -
Impact of bone marrow mesenchymal stem cell immunomodulation on the osteogenic effects of laponite
by: Tao Li, et al.
Published: (2018-04-01) -
Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells.
by: Karin Ekström, et al.
Published: (2013-01-01) -
Establishment of human immortalized mesenchymal stem cells lines for the monitoring and analysis of osteogenic differentiation in living cells
by: Takashi Narai, et al.
Published: (2020-10-01)